Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares Gold Trust (IAU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares Gold Trust — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while iShares Gold Trust trades at $78.82 (market cap $61.03B). The key difference: iShares Gold Trust is the larger of the two by market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals.
| EW | IAU | |
|---|---|---|
Market Cap | $49.44B | $61.03B |
Volume | 3,508,027 | 3,374,602 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $95.18 | $101.57 |
52-Week Low | $72.65 | $74.21 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 49 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IAU shares declined 1.67% to $77.06 amid bearish technical signals, with moving averages and oscillators indicating selling pressure. The stock faces headwinds from rising Treasury yields and Federal Reserve rate uncertainty, though some analysts see potential for recovery if inflation data continues to soften. Recent news highlights gold's sensitivity to economic indicators and monetary policy expectations.
The outlook remains cautious with technical indicators favoring bearish momentum, but potential exists for rebound if rate-hike expectations diminish. Key risks include persistent high yields and dollar strength, while opportunities may emerge from safe-haven demand during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →
